Is it right for scientists to put the links between cholesterol reducing medication and cancer down to ‘chance’?

Back in July I wrote about a study (the so-called “SEAS” trial) in which two cholesterol agents (simvastatin and ezetimibe) taken in combination appeared to increase risk of cancer. The full results of this study were published this week in the New England Journal of Medicine [1] and can be read here. Alongside this [...]